NSC |
Compound |
Enrichment |
Correlation |
NSC 703544 |
Null |
0.0414190425892865 |
0.30451144 |
NSC 707904 |
Null |
0.0414190425892865 |
0.21400026 |
NSC 719715 |
Null |
0.0414190425892865 |
0.5191173 |
NSC 720299 |
Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane |
0.0414190425892865 |
0.46459902 |
NSC 720386 |
Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane |
0.0414190425892865 |
0.18014467 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0414190425892865 |
0.47987234 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.0414190425892865 |
0.40825875 |
NSC 735408 |
Null |
0.0414190425892865 |
0.49089297 |
NSC 740 |
Methotrexate |
0.0414190425892865 |
0.19161289 |
NSC 763059 |
Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride |
0.0414190425892865 |
0.11182778 |